Literature DB >> 22294790

Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management.

Susan Little1, Dorothee Bienzle, Lisa Carioto, Hugh Chisholm, Elizabeth O'Brien, Margie Scherk.   

Abstract

Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are common and important infectious disease agents of cats in Canada. Seroprevalence data for FeLV and FIV in various populations of Canadian cats are reviewed and recommendations for testing and management of infections by these viruses in cats in Canada are presented. Retrovirus testing in Canada is infrequent in comparison with the United States, and efforts should be focused on reducing physical and other barriers to testing, and on education of veterinarians, veterinary team members, and cat owners regarding the importance of testing. New test methodologies for FeLV and FIV are emerging, and should be independently evaluated in order to provide practitioners with information on test reliability. Finally, more information is needed on FIV subtypes in Canada to improve diagnostics and vaccines, and to provide information on disease outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22294790      PMCID: PMC3135027     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  42 in total

1.  Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.

Authors:  Regina Hofmann-Lehmann; Ravi Tandon; Felicitas S Boretti; Marina L Meli; Barbara Willi; Valentino Cattori; Maria A Gomes-Keller; Pete Ossent; Matthew C Golder; J Norman Flynn; Hans Lutz
Journal:  Vaccine       Date:  2005-09-19       Impact factor: 3.641

2.  Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats.

Authors:  P Cynda Crawford; Margaret R Slater; Julie K Levy
Journal:  J Am Vet Med Assoc       Date:  2005-05-01       Impact factor: 1.936

Review 3.  Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.

Authors:  Ruiyu Pu; James Coleman; James Coisman; Eiji Sato; Taishi Tanabe; Maki Arai; Janet K Yamamoto
Journal:  J Feline Med Surg       Date:  2005-02       Impact factor: 2.015

4.  Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.

Authors:  Andrea C Pepin; Ravi Tandon; Valentino Cattori; Eva Niederer; Barbara Riond; Barbara Willi; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Virus Res       Date:  2007-04-16       Impact factor: 3.303

5.  Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens.

Authors:  Kristin MacDonald; Julie K Levy; Sylvia J Tucker; P Cynda Crawford
Journal:  J Am Vet Med Assoc       Date:  2004-11-15       Impact factor: 1.936

6.  Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity.

Authors:  Julie K Levy; H Morgan Scott; Jessica L Lachtara; P Cynda Crawford
Journal:  J Am Vet Med Assoc       Date:  2006-02-01       Impact factor: 1.936

Review 7.  Efficacy and safety of a feline immunodeficiency virus vaccine.

Authors:  Chengjin Huang; Douglas Conlee; Jennifer Loop; Deborah Champ; Mike Gill; Hsien-Jue Steve Chu
Journal:  Anim Health Res Rev       Date:  2004-12       Impact factor: 2.615

8.  Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.

Authors:  Chengjin Huang; Douglas Conlee; Michael Gill; Hsien-Jue Steve Chu
Journal:  J Feline Med Surg       Date:  2010-02-18       Impact factor: 2.015

9.  Vertical transmission of feline immunodeficiency virus.

Authors:  L L O'Neil; M J Burkhard; L J Diehl; E A Hoover
Journal:  Semin Vet Med Surg (Small Anim)       Date:  1995-11

10.  Seroprevalences of feline leukemia virus and feline immunodeficiency virus in cats with abscesses or bite wounds and rate of veterinarian compliance with current guidelines for retrovirus testing.

Authors:  Carrie E Goldkamp; Julie K Levy; Charlotte H Edinboro; Jessica L Lachtara
Journal:  J Am Vet Med Assoc       Date:  2008-04-15       Impact factor: 1.936

View more
  10 in total

1.  Seroprevalence of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) in shelter cats on the island of Newfoundland, Canada.

Authors:  Hannah J Munro; Lesley Berghuis; Andrew S Lang; Laura Rogers; Hugh Whitney
Journal:  Can J Vet Res       Date:  2014-04       Impact factor: 1.310

2.  Concomitant feline immunodeficiency virus (FIV) and Mycoplasma haemofelis in a barn cat.

Authors:  Alejandra Ceballos-Vasquez
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

Review 3.  Critical Problems for Research in Animal Sheltering, a Conceptual Analysis.

Authors:  Kevin Horecka; Sue Neal
Journal:  Front Vet Sci       Date:  2022-04-01

4.  Comparison of risk factors for seropositivity to feline immunodeficiency virus and feline leukemia virus among cats: a case-case study.

Authors:  Bimal K Chhetri; Olaf Berke; David L Pearl; Dorothee Bienzle
Journal:  BMC Vet Res       Date:  2015-02-10       Impact factor: 2.741

5.  Feline immunodeficiency virus (FIV) env recombinants are common in natural infections.

Authors:  Paweł M Bęczkowski; Joseph Hughes; Roman Biek; Annette Litster; Brian J Willett; Margaret J Hosie
Journal:  Retrovirology       Date:  2014-09-17       Impact factor: 4.602

6.  Occurrence of feline immunodeficiency virus and feline leukaemia virus in Maputo city and province, Mozambique: a pilot study.

Authors:  Cesaltina Clm Tchamo; Mónica De Rugeriis; Emília V Noormahomed
Journal:  JFMS Open Rep       Date:  2019-09-10

7.  Risk of Feline Immunodeficiency Virus (FIV) Infection in Pet Cats in Australia is Higher in Areas of Lower Socioeconomic Status.

Authors:  Vivian Tran; Mark Kelman; Michael Ward; Mark Westman
Journal:  Animals (Basel)       Date:  2019-08-21       Impact factor: 2.752

8.  Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias.

Authors:  Mehdi Abdollahi-Pirbazari; Shahram Jamshidi; Seyed Mahdi Nassiri; Mohamad Zamani-Ahmadmahmudi
Journal:  BMC Vet Res       Date:  2019-12-19       Impact factor: 2.741

Review 9.  Bioactive Compounds from Marine Sponges: Fundamentals and Applications.

Authors:  Disha Varijakzhan; Jiun-Yan Loh; Wai-Sum Yap; Khatijah Yusoff; Rabiha Seboussi; Swee-Hua Erin Lim; Kok-Song Lai; Chou-Min Chong
Journal:  Mar Drugs       Date:  2021-04-27       Impact factor: 5.118

10.  Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011).

Authors:  Bimal K Chhetri; Olaf Berke; David L Pearl; Dorothee Bienzle
Journal:  BMC Vet Res       Date:  2013-01-05       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.